236 related articles for article (PubMed ID: 26354285)
21. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
[TBL] [Abstract][Full Text] [Related]
22. Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma.
Lazarian G; Friedrich C; Quinquenel A; Tran J; Ouriemmi S; Dondi E; Martin A; Mihoub I; Chiron D; Bellanger C; Fleury C; Gélébart P; McCormack E; Ledoux D; Thieblemont C; Marzec J; Gribben JG; Cymbalista F; Varin-Blank N; Gardano L; Baran-Marszak F
Oncogene; 2020 Apr; 39(14):2934-2947. PubMed ID: 32034308
[TBL] [Abstract][Full Text] [Related]
23. Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling.
Pighi C; Gu TL; Dalai I; Barbi S; Parolini C; Bertolaso A; Pedron S; Parisi A; Ren J; Cecconi D; Chilosi M; Menestrina F; Zamò A
Cell Oncol (Dordr); 2011 Apr; 34(2):141-53. PubMed ID: 21394647
[TBL] [Abstract][Full Text] [Related]
24. FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.
Li Y; Bouchlaka MN; Wolff J; Grindle KM; Lu L; Qian S; Zhong X; Pflum N; Jobin P; Kahl BS; Eickhoff JC; Wuerzberger-Davis SM; Miyamoto S; Thomas CJ; Yang DT; Capitini CM; Rui L
Oncogene; 2016 Dec; 35(48):6223-6234. PubMed ID: 27157620
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma.
Rahal R; Frick M; Romero R; Korn JM; Kridel R; Chan FC; Meissner B; Bhang HE; Ruddy D; Kauffmann A; Farsidjani A; Derti A; Rakiec D; Naylor T; Pfister E; Kovats S; Kim S; Dietze K; Dörken B; Steidl C; Tzankov A; Hummel M; Monahan J; Morrissey MP; Fritsch C; Sellers WR; Cooke VG; Gascoyne RD; Lenz G; Stegmeier F
Nat Med; 2014 Jan; 20(1):87-92. PubMed ID: 24362935
[TBL] [Abstract][Full Text] [Related]
26. The role of B cell antigen receptors in mantle cell lymphoma.
Fichtner M; Dreyling M; Binder M; Trepel M
J Hematol Oncol; 2017 Oct; 10(1):164. PubMed ID: 29041946
[TBL] [Abstract][Full Text] [Related]
27. Advances in Molecular Biology and Targeted Therapy of Mantle Cell Lymphoma.
Klener P
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500350
[TBL] [Abstract][Full Text] [Related]
28. Could DNA-reactive B lymphocytes be activated through HIV-1 DNA-stimulation involving BCR/TLR-9 pathway to yield antibodies targeting viral DNA?
Norelli S
Med Hypotheses; 2014 Dec; 83(6):659-63. PubMed ID: 25441838
[TBL] [Abstract][Full Text] [Related]
29. Identification of a new gene regulatory circuit involving B cell receptor activated signaling using a combined analysis of experimental, clinical and global gene expression data.
Schrader A; Meyer K; Walther N; Stolz A; Feist M; Hand E; von Bonin F; Evers M; Kohler C; Shirneshan K; Vockerodt M; Klapper W; Szczepanowski M; Murray PG; Bastians H; Trümper L; Spang R; Kube D
Oncotarget; 2016 Jul; 7(30):47061-47081. PubMed ID: 27166259
[TBL] [Abstract][Full Text] [Related]
30. B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression.
Gambino S; Quaglia FM; Galasso M; Cavallini C; Chignola R; Lovato O; Giacobazzi L; Caligola S; Adamo A; Putta S; Aparo A; Ferrarini I; Ugel S; Giugno R; Donadelli M; Dando I; Krampera M; Visco C; Scupoli MT
Sci Rep; 2024 Mar; 14(1):6595. PubMed ID: 38503806
[TBL] [Abstract][Full Text] [Related]
31. Modulation of immune checkpoint molecule expression in mantle cell lymphoma.
Harrington BK; Wheeler E; Hornbuckle K; Shana'ah AY; Youssef Y; Smith L; Hassan Q; Klamer B; Zhang X; Long M; Baiocchi RA; Maddocks K; Johnson AJ; Byrd JC; Alinari L
Leuk Lymphoma; 2019 Oct; 60(10):2498-2507. PubMed ID: 30821551
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
Teshima K; Nara M; Watanabe A; Ito M; Ikeda S; Hatano Y; Oshima K; Seto M; Sawada K; Tagawa H
Oncogene; 2014 Apr; 33(17):2191-203. PubMed ID: 23686310
[TBL] [Abstract][Full Text] [Related]
33. Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations.
Wu C; de Miranda NF; Chen L; Wasik AM; Mansouri L; Jurczak W; Galazka K; Dlugosz-Danecka M; Machaczka M; Zhang H; Peng R; Morin RD; Rosenquist R; Sander B; Pan-Hammarström Q
Oncotarget; 2016 Jun; 7(25):38180-38190. PubMed ID: 27224912
[TBL] [Abstract][Full Text] [Related]
34. CD40L mediated alternative NFκB-signaling induces resistance to BCR-inhibitors in patients with mantle cell lymphoma.
Rauert-Wunderlich H; Rudelius M; Berberich I; Rosenwald A
Cell Death Dis; 2018 Jan; 9(2):86. PubMed ID: 29367645
[TBL] [Abstract][Full Text] [Related]
35. Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.
Yi S; Yan Y; Jin M; Bhattacharya S; Wang Y; Wu Y; Yang L; Gine E; Clot G; Chen L; Yu Y; Zou D; Wang J; Phan AT; Cui R; Li F; Sun Q; Zhai Q; Wang T; Yu Z; Liu L; Liu W; Lyv R; Sui W; Huang W; Xiong W; Wang H; Li C; Xiao Z; Hao M; Wang J; Cheng T; Bea S; Herrera AF; Danilov A; Campo E; Ngo VN; Qiu L; Wang L
J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34882582
[TBL] [Abstract][Full Text] [Related]
36. BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathway.
Pone EJ; Zhang J; Mai T; White CA; Li G; Sakakura JK; Patel PJ; Al-Qahtani A; Zan H; Xu Z; Casali P
Nat Commun; 2012 Apr; 3():767. PubMed ID: 22473011
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes.
Chatzouli M; Ntoufa S; Papakonstantinou N; Chartomatsidou E; Anagnostopoulos A; Kollia P; Ghia P; Muzio M; Stamatopoulos K; Belessi C
J Immunol; 2014 May; 192(10):4518-24. PubMed ID: 24719462
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.
Musilova K; Mraz M
Leukemia; 2015 May; 29(5):1004-17. PubMed ID: 25541152
[TBL] [Abstract][Full Text] [Related]
39. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma.
Rinaldi A; Kwee I; Taborelli M; Largo C; Uccella S; Martin V; Poretti G; Gaidano G; Calabrese G; Martinelli G; Baldini L; Pruneri G; Capella C; Zucca E; Cotter FE; Cigudosa JC; Catapano CV; Tibiletti MG; Bertoni F
Br J Haematol; 2006 Feb; 132(3):303-16. PubMed ID: 16409295
[TBL] [Abstract][Full Text] [Related]
40. Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation.
Fonte E; Agathangelidis A; Reverberi D; Ntoufa S; Scarfò L; Ranghetti P; Cutrona G; Tedeschi A; Xochelli A; Caligaris-Cappio F; Ponzoni M; Belessi C; Davis Z; Piris MA; Oscier D; Ghia P; Stamatopoulos K; Muzio M
Haematologica; 2015 Nov; 100(11):1460-8. PubMed ID: 26294727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]